ConductScience.org, home

Paper34604239

miR-29b-3p Increases Radiosensitivity in Stemness Cancer Cells via Modulating Oncogenes Axis.

Pan D and 6 others. Front Cell Dev Biol, 2021. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. miR-29b-3p Increases Radiosensitivity in Stemness Cancer Cells via Modulating Oncogenes Axis. Papers, record 34604239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34604239

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
miR-29b-3p Increases Radiosensitivity in Stemness Cancer Cells via Modulating Oncogenes Axis.
PubMed
Journal
Front Cell Dev Biol
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
1.05
iCite
Revised in PubMed
2021-10-05
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pan DDong
2Du YYarong
3Li RRong
4Shen AAihua
5Liu XXiaodong
6Li CChuanyuan
7Hu BBurong

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References64

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122214600The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury.Physiol Genomics2012https://conductscience.org/library/papers/22214600PubMed
217524393Cell shape regulates global histone acetylation in human mammary epithelial cells.Exp Cell Res2007https://conductscience.org/library/papers/17524393PubMed
325767398The role of miR-29b in cancer: regulation, function, and signaling.Onco Targets Ther2015https://conductscience.org/library/papers/25767398PubMed
411316541Apoptosis and bcl-2 expression as predictors of survival in radiation-treated non-small-cell lung cancer.Int J Radiat Oncol Biol Phys2001https://conductscience.org/library/papers/11316541PubMed
524909176c-Myc suppresses microRNA-29b to promote tumor aggressiveness and poor outcomes in non-small cell lung cancer by targeting FHIT.Oncogene2015https://conductscience.org/library/papers/24909176PubMed
626716904Cancer stem cells and signaling pathways in radioresistance.Oncotarget2016https://conductscience.org/library/papers/26716904PubMed
724872697Enhancement of radiotherapy efficacy by miR-200c-loaded gelatinase-stimuli PEG-Pep-PCL nanoparticles in gastric cancer cells.Int J Nanomedicine2014https://conductscience.org/library/papers/24872697PubMed
817185610Side population analysis using a violet-excited cell-permeable DNA binding dye.Stem Cells2007https://conductscience.org/library/papers/17185610PubMed
926984757An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells.Cancer Res2016https://conductscience.org/library/papers/26984757PubMed
1024091622Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma.Br J Cancer2013https://conductscience.org/library/papers/24091622PubMed
1130944638c-Myc maintains the self-renewal and chemoresistance properties of colon cancer stem cells.Oncol Lett2019https://conductscience.org/library/papers/30944638PubMed
1226175931PI3K/Akt/mTOR signaling pathway in cancer stem cells: from basic research to clinical application.Am J Cancer Res2015https://conductscience.org/library/papers/26175931PubMed
1320442295Three-dimensional cell growth confers radioresistance by chromatin density modification.Cancer Res2010https://conductscience.org/library/papers/20442295PubMed
1424206455microRNAs in cancer cell response to ionizing radiation.Antioxid Redox Signal2014https://conductscience.org/library/papers/24206455PubMed
1519079265miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42.Nat Struct Mol Biol2009https://conductscience.org/library/papers/19079265PubMed
1621951844Overexpression of microRNA-29b induces apoptosis of multiple myeloma cells through down regulating Mcl-1.Biochem Biophys Res Commun2011https://conductscience.org/library/papers/21951844PubMed
1725568669The Bcl-2 inhibitor Obatoclax overcomes resistance to histone deacetylase inhibitors SAHA and LBH589 as radiosensitizers in patient-derived glioblastoma stem-like cells.Genes Cancer2014https://conductscience.org/library/papers/25568669PubMed
1827527863Radiation induces premature chromatid separation via the miR-142-3p/Bod1 pathway in carcinoma cells.Oncotarget2016https://conductscience.org/library/papers/27527863PubMed
1917179479The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation.J Natl Cancer Inst2006https://conductscience.org/library/papers/17179479PubMed
2020041405Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma.Hepatology2010https://conductscience.org/library/papers/20041405PubMed

See all 64 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
41606241Loss of MicroRNA-29b promotes DNMT3b-mediated STING downregulation to attenuate radiotherapy-induced antitumor immunity in KRAS-mutated colorectal cancer.NPJ Precis Oncol2026https://conductscience.org/library/papers/41606241PubMed
41493679The epigenetic regulator SETDB1 as a key component of cancer stem cells and drug resistance in primary liver cancer.Cell Oncol (Dordr)2026https://conductscience.org/library/papers/41493679PubMed
41400771High TRA2B expression mediated by ncRNA correlates with adverse outcomes and tumor immune infiltration in hepatocellular carcinoma.Discov Oncol2025https://conductscience.org/library/papers/41400771PubMed
41375031Epigenetic and Transcriptional Reprogramming in 3D Culture Models in Breast Cancer.Cancers (Basel)2025https://conductscience.org/library/papers/41375031PubMed
40710326Regulatory Functions of microRNAs in Cancer Stem Cells: Mechanism, Facts, and Perspectives.Cells2025https://conductscience.org/library/papers/40710326PubMed
39917986Unleashing the power of urine‑based biomarkers in diagnosis, prognosis and monitoring of bladder cancer (Review).Int J Oncol2025https://conductscience.org/library/papers/39917986PubMed
39545960Non-coding RNAs modulation in breast cancer radioresponse: mechanisms and therapeutic implications.Strahlenther Onkol2025https://conductscience.org/library/papers/39545960PubMed
37958993Unraveling the Potential of miRNAs from CSCs as an Emerging Clinical Tool for Breast Cancer Diagnosis and Prognosis.Int J Mol Sci2023https://conductscience.org/library/papers/37958993PubMed
37569824Connection between Radiation-Regulating Functions of Natural Products and miRNAs Targeting Radiomodulation and Exosome Biogenesis.Int J Mol Sci2023https://conductscience.org/library/papers/37569824PubMed
37416747Identification of hub genes and microRNAs with prognostic values in esophageal cancer by integrated analysis.Noncoding RNA Res2023https://conductscience.org/library/papers/37416747PubMed
37373065In Silico Identification of a BRCA1:miR-29:DNMT3 Axis Involved in the Control of Hormone Receptors in BRCA1-Associated Breast Cancers.Int J Mol Sci2023https://conductscience.org/library/papers/37373065PubMed
36902482Discovering the Biological Significance and Therapeutic Potential of miR-29b-3p in Triple-Negative Breast Cancer.Int J Mol Sci2023https://conductscience.org/library/papers/36902482PubMed
36140539Mir-29b in Breast Cancer: A Promising Target for Therapeutic Approaches.Diagnostics (Basel)2022https://conductscience.org/library/papers/36140539PubMed
35743776Vav1 Selectively Down-Regulates Akt2 through miR-29b in Certain Breast Tumors with Triple Negative Phenotype.J Pers Med2022https://conductscience.org/library/papers/35743776PubMed
35628157Cellular and Molecular Profiling of Tumor Microenvironment and Early-Stage Lung Cancer.Int J Mol Sci2022https://conductscience.org/library/papers/35628157PubMed

Download CSV of cited by

Genes17

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34604239

GET https://conductscience.org/api/papers/v1/34604239/references?page=2